Drug Delivery

Nov 13, 2015
BioPharm International
By BioPharm International Editors
A new consortium involving Arecor, Fujifilm Diosynth Biotechnologies, and the UK's Center for Process Innovation will focus on formulation innovation as a way to improve downstream processing and reduce biopharmaceutical cost.
Oct 14, 2015
By BioPharm International Editors
The company presented a portfolio of new products during the meeting in Madrid.
Oct 02, 2015
BioPharm International
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
Sep 28, 2015
By BioPharm International Editors
Although the Committee for Medicinal Products for Human Use (CHMP) gave Blincyto a positive opinion, full approval of the drug in the EMA will rely on additional clinical studies.
Sep 16, 2015
Under terms of the agreement, Amgen will license Xencor’s XmAb technology platform for five Amgen programs and one Xencor program.
Sep 14, 2015
By BioPharm International Editors
Abenza acquired biopharmaceutical CDMO PacificGMP and expanded the company’s San Diego facility.
Sep 02, 2015
By BioPharm International Editors
The collaborative effort will be focused on fully humanized antibodies.
Aug 28, 2015
By BioPharm International Editors
The Pre-Connect Congress will explore pharma industry trends, such as mergers and acquisitions, the biologics market outlook, and innovation in drug delivery among others.
Aug 26, 2015
By BioPharm International Editors
Merus announced new investors and the sale of $80.5 million in shares to advance its immuno-oncology programs.
Aug 26, 2015
The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.
native1_300x100
lorem ipsum